IvyRock Asset Management (HK) Ltd

Position in PRME — Prime Medicine, Inc.

CIK 1809525 SHEUNG WAN, K3

Position in PRME

as of Jun 30, 2026 · filed Aug 4, 2026 Compact

Position Value

$154,242

+$8,778 QoQ

Shares Held

41,800

0.0% QoQ

Ownership

0.023%

of shares outstanding

% of Portfolio

0.09%

of 13F equity value

Holder Rank

#94

of 186 holders

Holding Since

Sep 2025

4 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

IvyRock Asset Management (HK) Ltd holds $24,322,044 across 5 Biotechnology names. PRME ranks #5 (0.6% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	LEGN	Legend Biotech Corp	801,000	$23,132,880
2	ARWR	Arrowhead Pharmaceuticals, Inc.	7,000	$570,570
3	BEAM	Beam Therapeutics Inc.	8,600	$295,152
4	NTLA	Intellia Therapeutics, Inc.	10,000	$169,200
5	PRME	Prime Medicine, Inc. This page	41,800	$154,242

4 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$154,242	41,800	0.0%	Shares	Sole	2026-08-04
2026-03-31	$145,464	41,800	0.0%	Shares	Sole	2026-05-07
2025-12-31	$145,046	41,800	0.0%	Shares	Sole	2026-02-11
2025-09-30	$231,572	41,800	—	Shares	Sole	2025-11-12
No filing history on record for this holder in this stock.